The Royal Children's Hospital is a major children's hospital in Melbourne, Australia. As a major specialist paediatric hospital in Victoria, the Royal Children's Hospital provides a full range of clinical services, tertiary care, as well as health promotion and prevention programs for children and young people.

There are 340 beds in Royal Children's Hospital.

During the past decade, Royal Children's Hospital conducted 141 clinical trials. In the 10-year time frame, 141 clinical trials started and 66 clinical trials were completed, i.e. on average, 46.8% percent of trials that started reached the finish line to date. In the past 5 years, 67 clinical trials started and 38 clinical trials were completed. i.e. 56.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Royal Children's Hospital" #1 sponsor was "Children's Oncology Group" with 74 trials, followed by "Murdoch Childrens Research Institute" with 23 trials sponsored, "National Cancer Institute (NCI)" with 17 trials sponsored, "Vertex Pharmaceuticals Incorporated" with 15 trials sponsored and "Eli Lilly and Company" with 15 trials sponsored. Other sponsors include 121 different institutions and companies that sponsored additional 86 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Royal Children's Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 77 trials as a collaborator, "Royal Children's Hospital" with 11 trials as a collaborator, "Sydney Children's Hospitals Network" with 5 trials as a collaborator, "Cooperative International Neuromuscular Research Group" with 4 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 4 trials as a collaborator. Other collaborators include 146 different institutions and companies that were collaborators in the rest 122 trials.

According to Clinical.Site data, the most researched conditions in "Royal Children's Hospital" are "Cystic Fibrosis" (22 trials), "Leukemia" (14 trials), "Duchenne Muscular Dystrophy" (11 trials), "Sarcoma" (11 trials) and "Neuroblastoma" (8 trials). Many other conditions were trialed in "Royal Children's Hospital" in a lesser frequency.

Most popular intervention types in "Royal Children's Hospital" are "Drug" (202 trials), "Biological" (49 trials), "Other" (47 trials), "Radiation" (38 trials) and "Procedure" (35 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (30 trials), "Cyclophosphamide" (23 trials), "cyclophosphamide" (22 trials), "Laboratory Biomarker Analysis" (19 trials) and "Etoposide" (18 trials). Other intervention names were less common.

The vast majority of trials in "Royal Children's Hospital" are 243 trials for "All" genders, 18 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Royal Children's Hospital". undefined are not yet recruiting, 51 are recruiting, 46 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 144 completed trials in Royal Children's Hospital, 1 suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Royal Children's Hospital, 42 "Phase 1" clinical trials were conducted, 73 "Phase 2" clinical trials and 116 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 12 trials, and there were also 11 trials that are defined as “Not Applicable".

Royal Children's Hospital has several departments that took part in Clinical trials: "Royal Children's Hospital Melbourne - PIN" - 5 trials, "Royal Children'S Hospital; Paediatric Rheumatology" - 3 trials, "Royal Children'S Hospital; Department of Nephrology" - 2 trials, "Royal Children's Hospital Melbourne, Cardiology - Site 5001" - 2 trials